1. Single‐surgeon parotidectomy outcomes in an academic center experience during a 15‐year period
- Author
-
Chandler Shapiro, Rosh K. V. Sethi, Nicholas Koen, Elliana Kirsh DeVore, Elliott D. Kozin, Daniel G. Deschler, and Vivek V. Kanumuri
- Subjects
medicine.medical_specialty ,Weakness ,Head and Neck, and Tumor Biology ,Malignant disease ,03 medical and health sciences ,0302 clinical medicine ,academic ,extracapsular dissection ,parotid tumor ,Epidemiology ,medicine ,030223 otorhinolaryngology ,parotidectomy ,Paresis ,Original Research ,facial nerve monitoring ,business.industry ,national ,General Medicine ,Parotidectomy ,Facial nerve ,Single surgeon ,Surgery ,single‐surgeon ,trend ,Superficial Parotidectomy ,parotid ,030220 oncology & carcinogenesis ,parotid mass ,epidemiology ,facial nerve ,medicine.symptom ,business - Abstract
Objective As large single‐surgeon series in the literature are lacking, we sought to review a single‐surgeon's experience with parotidectomy in an academic center, with a focused analysis of pathology, technique, and facial nerve (FN) weakness. Benchmark values for complications and operative times with routine trainee involvement and without continuous FN monitoring are offered. Materials and Methods All patients who underwent parotidectomy, performed by D. G. D., for benign and malignant disease between January 2004 and December 2018 at an academic center were reviewed. Results A total of 924 parotidectomies, with adequate evaluatable data were identified. The majority of patients had benign tumors (70.9%). Partial/superficial parotidectomy was the most common approach (65.7%). Selective FN branch sacrifice was rare (12.3%), but significantly more common among patients with malignant pathology (33.8% vs 3.5% for benign, P
- Published
- 2020